![Karen Eaton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karen Eaton was the founder of Sigma Genetics, Inc. (founded in 2016) where she held the title of Chief Executive Officer from 2016 to 2017.
She is currently working as a Venture Partner at Pioneer Fund since 2022.
Ms. Eaton has an MBA and a doctorate from the University of Washington.
| Unternehmen | Position | Beginn |
|---|---|---|
Pioneer Fund/NY/
 Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund invests in companies located across the globe. The firm targets companies operating in the fields of biotechnology, healthcare and life sciences sectors. It provides financing for seed and early stage capital requirements. | Private Equity Investor | 01.01.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
Sigma Genetics, Inc.
 Sigma Genetics, Inc. Medical SpecialtiesHealth Technology Manufactures non-invasive devices | Vorstandsvorsitzender | 01.10.2017 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pioneer Fund/NY/
Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund invests in companies located across the globe. The firm targets companies operating in the fields of biotechnology, healthcare and life sciences sectors. It provides financing for seed and early stage capital requirements. | Finance |
Sigma Genetics, Inc.
Sigma Genetics, Inc. Medical SpecialtiesHealth Technology Manufactures non-invasive devices | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
